CW Stock Analysis: Curtiss-Wright | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 17.123m USD | 12M Return: -16.4% | US2315611010 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 181M
EPS Trend: 99.8%
Qual. Beats: 1
Rev. Trend: 99.8%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Curtiss-Wright Corporation (NYSE: CW) is a U.S.-based provider of engineered products, solutions, and services serving the aerospace and defense, commercial nuclear power, process, and industrial markets worldwide. Founded in 1929 and headquartered in Davidson, North Carolina, the company operates through three segments: Aerospace & Industrial, Defense Electronics, and Naval & Power, offering a broad portfolio that includes industrial vehicle components, avionics, embedded computing systems, naval propulsion equipment, reactor coolant pumps, and severe-service valve technologies.
As a large-cap industrial company classified within the Aerospace & Defense sub-industry, Curtiss-Wright benefits from operating in highly regulated end markets with significant barriers to entry. Its business model is geared toward long product lifecycles and mission-critical applications, with a substantial portion of revenue tied to U.S. defense, naval, and commercial nuclear power customers, including direct support work for the U.S. Navy.
- U.S. Navy shipbuilding backlog expansion drives Naval & Power segment growth
- Defense Electronics bookings surge on embedded computing and weapons handling demand
- Commercial nuclear reactor coolant pump backlog benefits from energy security initiatives
| Net Income: 555.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 0.85 > 1.0 |
| NWC/Revenue: 17.26% < 20% (prev 24.47%; Δ -7.21% < -1%) |
| CFO/TA 0.13 > 3% & CFO 708.7m > Net Income 555.2m |
| Net Debt (1.05b) to EBITDA (865.8m): 1.21 < 3 |
| Current Ratio: 1.42 > 1.5 & < 3 |
| Outstanding Shares: last quarter (36.9m) vs 12m ago -2.48% < -2% |
| Gross Margin: 38.07% > 18% (prev 37.43%; Δ 0.64% > 0.5%) |
| Asset Turnover: 71.36% > 50% (prev 66.16%; Δ 5.20% > 0%) |
| Interest Coverage Ratio: 17.76 > 6 (EBIT TTM 749.2m / Interest Expense TTM 42.2m) |
| A: 0.12 (Total Current Assets 2.17b - Total Current Liabilities 1.52b) / Total Assets 5.37b |
| B: 0.88 (Retained Earnings 4.70b / Total Assets 5.37b) |
| C: 0.14 (EBIT TTM 749.2m / Avg Total Assets 5.24b) |
| D: 0.91 (Book Value of Equity 2.56b / Total Liabilities 2.81b) |
| Altman-Z'' = 5.56 = AAA |
| DSRI: 0.97 (Receivables 1.05b/976.9m, Revenue 3.74b/3.38b) |
| GMI: 0.98 (GM 37.43% / 38.07%) |
| AQI: 0.94 (AQ_t 0.48 / AQ_t-1 0.51) |
| SGI: 1.11 (Revenue 3.74b / 3.38b) |
| TATA: -0.03 (NI 555.2m - CFO 708.7m) / TA 5.37b) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of November 17, 2026, the stock is trading at USD 453.91 with a total of 225,311 shares traded. Over the past week, the price has changed by -5.83%, over one month by -9.64%, over three months by -34.76% and over the past year by -16.39%.
Current recommended Stop Loss: 429.30 (which is 5.4% or 1.3 ATR below the current price).
Curtiss-Wright has received a consensus analysts rating of 4.22. Therefore, it is recommended to buy CW.
- StrongBuy: 5
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 627.4 | 38.2% |
P/E Trailing = 31.4917
P/E Forward = 28.4091
P/S = 4.5816
P/B = 6.6897
P/EG = 1.9966
Revenue TTM = 3.74b USD
EBIT TTM = 749.2m USD
EBITDA TTM = 865.8m USD
Long Term Debt = 757.1m USD (from longTermDebt, last quarter)
Short Term Debt = 200.0m USD (from shortTermDebt, last quarter)
Debt = 1.33b USD (from shortLongTermDebtTotal, last quarter) + Leases 187.2m
Net Debt = 1.05b USD (calculated: Debt 1.33b - CCE 281.1m)
Enterprise Value = 18.2b USD (17.1b + Debt 1.33b - CCE 281.1m)
Interest Coverage Ratio = 17.76 (Ebit TTM 749.2m / Interest Expense TTM 42.2m)
EV/FCF = 30.82x (Enterprise Value 18.2b / FCF TTM 589.7m)
FCF Yield = 3.25% (FCF TTM 589.7m / Enterprise Value 18.2b)
FCF Margin = 15.78% (FCF TTM 589.7m / Revenue TTM 3.74b)
Net Margin = 14.86% (Net Income TTM 555.2m / Revenue TTM 3.74b)
Gross Margin = 38.07% ((Revenue TTM 3.74b - Cost of Revenue TTM 2.31b) / Revenue TTM)
Gross Margin QoQ = 39.01% (prev 39.40%)
Tobins Q-Ratio = 3.38 (Enterprise Value 18.2b / Total Assets 5.37b)
Interest Expense / Debt = 3.17% (Interest Expense 42.2m / Debt 1.33b)
Taxrate = 21.47% (151.8m / 707.0m)
NOPAT = 588.4m (EBIT 749.2m * (1 - 21.47%))
Current Ratio = 1.42 (Total Current Assets 2.17b / Total Current Liabilities 1.52b)
Debt / Equity = 0.52 (Debt 1.33b / totalStockholderEquity, last quarter 2.56b)
Debt / EBITDA = 1.21 (Net Debt 1.05b / EBITDA 865.8m)
Debt / FCF = 1.78 (Net Debt 1.05b / FCF TTM 589.7m)
Total Stockholder Equity = 2.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.60% (Net Income 555.2m / Total Assets 5.37b)
RoE = 21.16% (Net Income TTM 555.2m / Total Stockholder Equity 2.62b)
RoCE = 22.16% (EBIT 749.2m / Capital Employed (Equity 2.62b + L.T.Debt 757.1m))
RoIC = 15.22% (NOPAT 588.4m / Invested Capital 3.86b)
WACC = 9.54% (E(17.1b)/V(18.5b) * Re(10.09%) + D(1.33b)/V(18.5b) * Rd(3.17%) * (1-Tc(0.21)))
Discount Rate = 10.09% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.18 | Cagr: -1.93%
[DCF] Terminal Value 74.06% ; FCFF base≈560.5m ; Y1≈637.9m ; Y5≈921.6m
[DCF] Fair Price = 287.7 (EV 11.5b - Net Debt 1.05b = Equity 10.4b / Shares 36.3m; r=9.54% [WACC]; 5y FCF grow 14.15% → 2.50% )
EPS Correlation: 99.80 | EPS CAGR: 18.48% | SUE: 1.55 | # QB: 1
Revenue Correlation: 99.82 | Revenue CAGR: 10.53% | SUE: 0.79 | # QB: 0
EPS current Quarter (2027-03-31): EPS=3.84 | Chg30d=+0.43% | Revisions=+57% | Analysts=5
EPS current Year (2026-12-31): EPS=15.53 | Chg30d=+1.42% | Revisions=+70% | GrowthEPS=+17.4% | GrowthRev=+9.4%
EPS next Year (2027-12-31): EPS=17.52 | Chg30d=+2.10% | Revisions=+55% | GrowthEPS=+12.8% | GrowthRev=+8.5%
[Analyst] Revisions Ratio: +77% (up=18, down=1)